Mark D. Black

Affiliations: 
sanofi-aventis.com, St. Louis, MO, United States 
Area:
Neuroscience
Google:
"Mark Black"
Mean distance: 18.82 (cluster 17)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Griebel G, Pichat P, Boulay D, et al. (2016) The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophrenia. Scientific Reports. 6: 35320
Black MD. (2015) Never hold the patient culpable for a bad outcome--perhaps we were in part incorrect. The Journal of Thoracic and Cardiovascular Surgery. 149: 624-5
Naimoli V, Featherstone R, Potestio L, et al. (2015) Compound A, a novel, potent and selective mGluR2 positive allosteric modulator: III. Effects in clinically relevant translational cognition models that could be used as biomarkers F1000research. 4
Ross JA, Trussler RS, Black MD, et al. (2014) Tn5 transposition in Escherichia coli is repressed by Hfq and activated by over-expression of the small non-coding RNA SgrS. Mobile Dna. 5: 27
Black MD, Kaneshiro R, Lai JI, et al. (2014) Hereditary diffuse gastric cancer associated with E-cadherin germline mutation: a case report. Hawai'I Journal of Medicine & Public Health : a Journal of Asia Pacific Medicine & Public Health. 73: 204-7
Black MD, Vigorito MC, Curtis JR, et al. (2013) A multifaceted intervention to improve compliance with process measures for ICU clinician communication with ICU patients and families. Critical Care Medicine. 41: 2275-83
Griebel G, Pichat P, Pruniaux MP, et al. (2012) SAR110894, a potent histamine H₃-receptor antagonist, displays procognitive effects in rodents. Pharmacology, Biochemistry, and Behavior. 102: 203-14
Black MD, Schorr C, Levy MM. (2012) Knowledge translation and the multifaceted intervention in the intensive care unit. Critical Care Medicine. 40: 1324-8
Black MD, Stevens RJ, Rogacki N, et al. (2011) AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents. Psychopharmacology. 215: 149-63
Liang G, Neuenschwander K, Chen X, et al. (2011) Structure-based design, synthesis, and profiling of potent and selective neuronal nitric oxide synthase (nNOS) inhibitors with an amidinothiophene hydroxypiperidine scaffold Medchemcomm. 2: 201-205
See more...